Paloma Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-81,200
Closed -$12.7M 933
2023
Q4
$12.7M Buy
+81,200
New +$12.5M 0.47% 31
2019
Q2
Sell
-41,800
Closed -$5.84M 1974
2019
Q1
$5.84M Buy
+41,800
New +$5.6M 0.14% 141
2018
Q4
Sell
-58,100
Closed -$8.03M 1525
2018
Q3
$8.03M Sell
58,100
-21,900
-27% -$2.91M 0.15% 102
2018
Q2
$9.71M Buy
+80,000
New +$9.98M 0.18% 90
2017
Q4
Sell
-25,000
Closed -$3.25M 2102
2017
Q3
$3.25M Buy
+25,000
New +$3.31M 0.04% 447
2017
Q2
Sell
-124,500
Closed -$15.5M 2310
2017
Q1
$15.5M Buy
124,500
+94,700
+318% +$11.3M 0.19% 74
2016
Q4
$3.43M Sell
29,800
-53,700
-64% -$6.2M 0.03% 411
2016
Q3
$9.86M Buy
83,500
+59,500
+248% +$7.22M 0.12% 101
2016
Q2
$2.91M Buy
+24,000
New +$2.73M 0.03% 484
2014
Q4
Sell
-8,400
Closed -$895K 1253
2014
Q3
$895K Sell
8,400
-15,100
-64% -$1.57M 0.04% 367
2014
Q2
$2.46M Buy
+23,500
New +$2.38M 0.1% 194

Other funds holding JNJ

Paloma Partners's JNJ Position: Q4 2024 in Review

Paloma Partners sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 1,439 shares — an estimated $233K sold.

Paloma Partners first reported a position in JNJ in Q2 2013 and held it in 36 quarters. The position peaked at $32.5M in Q2 2020. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

  • Paloma Partners reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 1,439 Johnson & Johnson shares in Q4 2024, an estimated $233K.
  • Paloma Partners first reported a position in Johnson & Johnson in Q2 2013 and held it in 36 quarters.
  • Paloma Partners's Johnson & Johnson position peaked at $32.5M in Q2 2020.
  • 4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.